Techno Medica Co., Ltd. (6678.T)
JPY 1749.0
(0.11%)
JPY 1749.0
(0.11%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.34 Billion JPY | 17.15% |
| 2022 | 1.15 Billion JPY | -10.2% |
| 2021 | 1.28 Billion JPY | 11.11% |
| 2020 | 1.15 Billion JPY | 15.27% |
| 2019 | 1 Billion JPY | -8.89% |
| 2018 | 1.09 Billion JPY | -16.08% |
| 2017 | 1.3 Billion JPY | 185.62% |
| 2016 | 458.12 Million JPY | -61.73% |
| 2015 | 1.19 Billion JPY | -19.47% |
| 2014 | 1.48 Billion JPY | 9.7% |
| 2013 | 1.35 Billion JPY | 8.95% |
| 2012 | 1.24 Billion JPY | 15.76% |
| 2011 | 1.07 Billion JPY | 15.09% |
| 2010 | 933.52 Million JPY | 19.06% |
| 2009 | 784.07 Million JPY | -7.34% |
| 2008 | 846.21 Million JPY | -3.09% |
| 2007 | 873.23 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 173.52 Million JPY | -75.27% |
| 2023 Q4 | 701.75 Million JPY | 160.43% |
| 2023 FY | 1.34 Billion JPY | 17.15% |
| 2023 Q1 | 72.15 Million JPY | -87.7% |
| 2023 Q2 | 304.75 Million JPY | 322.35% |
| 2023 Q3 | 269.46 Million JPY | -11.58% |
| 2022 Q4 | 586.87 Million JPY | 130.48% |
| 2022 FY | 1.15 Billion JPY | -10.2% |
| 2022 Q1 | 87.31 Million JPY | -85.64% |
| 2022 Q2 | 221.91 Million JPY | 154.16% |
| 2022 Q3 | 254.63 Million JPY | 14.74% |
| 2021 Q4 | 608.23 Million JPY | 196.9% |
| 2021 FY | 1.28 Billion JPY | 11.11% |
| 2021 Q1 | 171.01 Million JPY | -71.64% |
| 2021 Q2 | 297.28 Million JPY | 73.84% |
| 2021 Q3 | 204.85 Million JPY | -31.09% |
| 2020 Q4 | 602.95 Million JPY | 124.43% |
| 2020 Q3 | 268.66 Million JPY | 20.68% |
| 2020 Q2 | 222.62 Million JPY | 277.23% |
| 2020 Q1 | 59.01 Million JPY | -82.08% |
| 2020 FY | 1.15 Billion JPY | 15.27% |
| 2019 Q3 | 177.4 Million JPY | -32.81% |
| 2019 Q4 | 329.31 Million JPY | 85.63% |
| 2019 Q1 | 229.69 Million JPY | -52.21% |
| 2019 Q2 | 264.02 Million JPY | 14.95% |
| 2019 FY | 1 Billion JPY | -8.89% |
| 2018 Q4 | 480.68 Million JPY | 238.57% |
| 2018 FY | 1.09 Billion JPY | -16.08% |
| 2018 Q3 | 141.97 Million JPY | -60.3% |
| 2018 Q2 | 357.58 Million JPY | 203.42% |
| 2018 Q1 | 117.85 Million JPY | -80.02% |
| 2017 FY | 1.3 Billion JPY | 185.62% |
| 2017 Q3 | 330.4 Million JPY | 151.71% |
| 2017 Q2 | 131.26 Million JPY | -48.91% |
| 2017 Q1 | 256.9 Million JPY | -39.48% |
| 2017 Q4 | 589.95 Million JPY | 78.56% |
| 2016 Q3 | 267.11 Million JPY | 198.48% |
| 2016 FY | 458.12 Million JPY | -61.73% |
| 2016 Q4 | 424.45 Million JPY | 58.9% |
| 2016 Q2 | -271.22 Million JPY | -817.93% |
| 2016 Q1 | 37.77 Million JPY | -91.79% |
| 2015 Q1 | 279.23 Million JPY | -55.87% |
| 2015 Q3 | 95.38 Million JPY | -81.18% |
| 2015 FY | 1.19 Billion JPY | -19.47% |
| 2015 Q4 | 459.94 Million JPY | 382.2% |
| 2015 Q2 | 506.95 Million JPY | 81.55% |
| 2014 Q2 | 529.97 Million JPY | 262.57% |
| 2014 Q1 | 146.17 Million JPY | -73.92% |
| 2014 Q4 | 632.77 Million JPY | 256.26% |
| 2014 FY | 1.48 Billion JPY | 9.7% |
| 2014 Q3 | 177.61 Million JPY | -66.49% |
| 2013 FY | 1.35 Billion JPY | 8.95% |
| 2013 Q2 | 423.93 Million JPY | 136.77% |
| 2013 Q1 | 179.04 Million JPY | -66.12% |
| 2013 Q4 | 560.44 Million JPY | 192.44% |
| 2013 Q3 | 191.64 Million JPY | -54.79% |
| 2012 Q3 | 208.34 Million JPY | -38.24% |
| 2012 Q2 | 337.34 Million JPY | 98.98% |
| 2012 FY | 1.24 Billion JPY | 15.76% |
| 2012 Q1 | 169.53 Million JPY | -62.95% |
| 2012 Q4 | 528.52 Million JPY | 153.68% |
| 2011 Q2 | 289.21 Million JPY | 156.54% |
| 2011 Q1 | 112.73 Million JPY | -77.44% |
| 2011 FY | 1.07 Billion JPY | 15.09% |
| 2011 Q3 | 214.88 Million JPY | -25.7% |
| 2011 Q4 | 457.58 Million JPY | 112.95% |
| 2010 Q1 | 66.77 Million JPY | -80.72% |
| 2010 Q3 | 79.64 Million JPY | -72.28% |
| 2010 Q2 | 287.34 Million JPY | 330.34% |
| 2010 FY | 933.52 Million JPY | 19.06% |
| 2010 Q4 | 499.76 Million JPY | 527.51% |
| 2009 FY | 784.07 Million JPY | -7.34% |
| 2009 Q2 | 276.52 Million JPY | 247.15% |
| 2009 Q1 | 79.65 Million JPY | -76.15% |
| 2009 Q3 | 81.57 Million JPY | -70.5% |
| 2009 Q4 | 346.31 Million JPY | 324.52% |
| 2008 Q4 | 334 Million JPY | 117.54% |
| 2008 Q2 | 335.01 Million JPY | 0.0% |
| 2008 Q3 | 153.53 Million JPY | -54.17% |
| 2008 FY | 846.21 Million JPY | -3.09% |
| 2007 FY | 873.23 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| DVx Inc. | 172.91 Million JPY | -679.658% |
| Seikagaku Corporation | 2.18 Billion JPY | 38.329% |
| Eiken Chemical Co., Ltd. | 2.63 Billion JPY | 48.818% |
| Create Medic Co., Ltd. | 154.02 Million JPY | -775.284% |
| PHC Holdings Corporation | -12.89 Billion JPY | 110.457% |
| Rion Co., Ltd. | 2.65 Billion JPY | 49.173% |
| Nihon Kohden Corporation | 17.02 Billion JPY | 92.082% |
| Fukuda Denshi Co., Ltd. | 18.69 Billion JPY | 92.788% |
| Japan Lifeline Co., Ltd. | 7.51 Billion JPY | 82.061% |
| Japan Medical Dynamic Marketing, INC. | 1.27 Billion JPY | -6.012% |
| 3-D Matrix, Ltd. | -255.5 Million JPY | 627.634% |
| CYBERDYNE Inc. | -1.47 Billion JPY | 191.337% |